Home » Stocks » ALC

Alcon, Inc. (ALC)

Stock Price: $70.17 USD 0.48 (0.69%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 31.61B
Revenue (ttm) 7.51B
Net Income (ttm) -656.00M
Shares Out 488.20M
EPS (ttm) -1.47
PE Ratio n/a
Forward PE 33.22
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $70.17
Previous Close $69.69
Change ($) 0.48
Change (%) 0.69%
Day's Open -
Day's Range 69.65 - 70.64
Day's Volume 0
52-Week Range 39.86 - 70.64

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Seeking Alpha - 5 days ago

Alcon, Inc. (ALC) Presents at JPMorgan Healthcare Conference - (Transcript)

Seeking Alpha - 1 month ago

Eye-care devices market is an attractive end-market supported by secular growth trends such as aging population, increased myopia prevalence, and innovation in products leading to better outco...

Seeking Alpha - 2 months ago

Alcon, Inc. (ALC) CEO David Endicott on Q3 2020 Results - Earnings Call Transcript

CNBC International TV - 2 months ago

Unable to provide full-year guidance due to difficult market conditions, Alcon CEO says

Alcon CEO David Endicott discusses the company's third-quarter earnings.

Benzinga - 2 months ago

Shares of Alcon (NYSE:ALC) rose 2.73% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 15.22% year over year to $0.39, which beat t...

Seeking Alpha - 4 months ago

Alcon Inc. (ALC) CEO David Endicott on Q2 2020 Results - Earnings Call Transcript

Seeking Alpha - 8 months ago

Alcon Inc. (ALC) CEO David Endicott on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 10 months ago

Alcon, Inc. (ALC) CEO David Endicott on Q4 2019 Results - Earnings Call Transcript

The Motley Fool - 11 months ago

The switch will increase the availability of pain and allergy drugs from GlaxoSmithKline and Alcon.

Other stocks mentioned: GSK

About ALC

Alcon, an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients. It operates through two segments, Surgical and Vision Care. The Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures, such as cataracts, vitreoretinal, refractive laser, and... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1945
CEO
David J. Endicott
Employees
20,000
Stock Exchange
NYSE
Ticker Symbol
ALC
Full Company Profile

Financial Performance

In 2019, Alcon's revenue was $7.51 billion, an increase of 4.96% compared to the previous year's $7.15 billion. Losses were -$656.00 million, 189.0% more than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Alcon is 68.00, which is a decrease of -3.09% from the latest price.

Price Target
$68.00
(-3.09% downside)